FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Workshop on AI Use in Drug/Biologic Development

FDA and the Clinical Trials Transformation Initiative announce an 8/6 hybrid public workshop on artificial intelligence in drug and biological product...

latest-news-card-1
Medical Devices

Pediatric Orthopedic Device Innovation Lags: Research

University of MissouriKansas City researchers say pediatric orthopedic device innovation lags substantially behind adult device innovation.

latest-news-card-1
Medical Devices

Diasorin Liaison Plex Assay Cleared

FDA clears a Diasorin 510(k) for its Liaison Plex Yeast Blood Culture Assay for microbiological diagnosis of bloodstream infections.

latest-news-card-1
Human Drugs

FDA Places Hold on Biomea Diabetes Trials

FDA places a clinical hold on Biomea Fusions Phase 1-2 clinical trials of its investigational covalent menin inhibitor BMF-219 in Type 2 and Type 1 di...

latest-news-card-1
Medical Devices

FDA Denies Nautilus Glove Reconsideration Request

FDA denies a Nautilus Gloves request that the agency not rescind its 510(k) clearance for nitrile exam gloves and instead allow the company to substit...

latest-news-card-1
Human Drugs

Questions on Alzheimers Drug Draft Guidance

Two stakeholders provide comments and questions on the latest FDA draft guidance on developing drugs to treat early Alzheimers disease.

latest-news-card-1
Medical Devices

Medtronic Recalls Malfunctioning StealthStation Software

Medtronic recalls (Class 1) five versions of its StealthStation S8 neurological navigation device after customer complaints about a software error.

latest-news-card-1
Medical Devices

Trexo Robotics Illegally Marketing Devices: FDA

FDA warns Mississauga, Canada-based Trexo Robotics Holdings about QS issues in its illegal manufacturing and marketing of robotic medical devices.

latest-news-card-1
Biologics

BIMO Electronic Submission Format Guidance

FDA publishes a draft guidance outlining the standardized format for electronic submission of BLA, NDA, and selected supplements for planning CBER Bio...

latest-news-card-1
Federal Register

Info Collection on Rx Drug Marketing

Federal Register notice: FDA sends to OMB an information collection extension entitled Prescription Drug Marketing.